Table 3.
Suggested reference limits for ulcerative colitis.
|
Included populations |
Sick populations |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test | Sex | N | % | Lower | 90%CI | Upper | 90%CI | N | Lower | 90%CI | Upper | 90%CI | Health-associated reference interval | |
|
ALP U/L |
M | 128 | 69% | 44 | (31–46) | 160 | (141–212) | 185 | 41 | (30–45) | 306 | (215–477) | 35–105 | |
| F | 108 | 81% | 31 | (25–36) | 134 | (123–175) | 134 | 33 | (30–37) | 393 | (146–458) | 35–105 | ||
|
ALT U/L |
F | 133 | 98% | 9 | (7-10) | 85 | (52–162) | 136 | 9 | (7-10) | 85 | (58–162) | 10–45 | |
|
Bilirubin μmol/L |
M | 147 | 82% | 3 | (3-4) | 43 | (26–49) | 179 | 4 | (3-4) | 49 | (32–62) | 5–25 | |
| F | 114 | 88% | 3 | (3-4) | 25 | (19–32) | 130 | 3 | (3-4) | 26 | (20–59) | 5–25 | ||
|
CK U/L |
M | 85 | 100% | 20 | (15-29) | 639 | (337–5573) | 85 | 20 | (15-29) | 639 | (337–5573) | < 50: 50–400; ≥ 50: 40-280 | |
| CRP mg/L | B | 86 | 27% | 5 | (5-5) | 61 | (43–121) | 318 | 5 | (5-5) | 114 | (72–157) | < 5 | |
| Calcium mmol/L | B | 82 | 28% | 2.17 | (2.15–2.21) | 2.56 | (2.49–2.59) | 296 | 2.04 | (1.91-2.11) | 2.56 | (2.54–2.58) | 2.15–2.51 | |
|
Creatinine μmol/L |
M | 169 | 90% | 53 | (44–59) | 134 | (104–183) | 188 | 53 | (44–60) | 216 | (161–363) | 60–105 | |
| F | 100 | 74% | 44 | (43–49) | 88 | (82–98) | 136 | 44 | (43–49) | 125 | (89–138) | 45–90 | ||
|
Ferritin μg/L |
F | 126 | 98% | 8 | [[5], [6], [7], [8], [9], [10], [11]] | 284 | (224–358) | 129 | 8 | [[5], [6], [7], [8], [9], [10], [11]] | 308 | (225–358) | 20–167 | |
|
GT U/L |
M | 138 | 75% | 11 | (10-12) | 202 | (125–402) | 183 | 11 | (10-14) | 557 | (334–1690) | < 40: 10–80; ≥ 40: 15-115 | |
| F | 105 | 80% | 9 | (9-10) | 167 | (100–594) | 131 | 10 | (9-10) | 333 | (146–484) | < 40: 10–45; ≥ 40: 10-75 | ||
| IgG g/L | B | 104 | 94% | 6.8 | (5.7–7.3) | 22.4 | (18.7–28.0) | 111 | 6.8 | (5.7–7.3) | 22.4 | (18.7–28.0) | F:19–50: 6.9-15.7; F > 50: 6.1-14.9; M: 6.1-14.9 | |
| Leukocytes x 109/L | M | 143 | 76% | 4.2 | (3.7–4.5) | 14.8 | (12.9–17.0) | 187 | 4.0 | (3.6–4.3) | 17.4 | (14.5-19.6) | 4.1–9.8 | |
| F | 110 | 81% | 3.7 | (3.1–4.0) | 12.8 | (11.2–16.8) | 136 | 3.8 | (3.4–4.0) | 12.4 | (11.2–13.9) | 4.1–9.8 | ||
| TSH mIU/L | M | 140 | 95% | 0.39 | (0.25–0.52) | 5.21 | (4.37–9.22) | 147 | 0.36 | (0.11–0.50) | 5.21 | (4.37–9.22) | 0.24–3.78 | |
| F | 108 | 92% | 0.23 | (0.01–0.51) | 3.93 | (3.35–4.19) | 118 | 0.19 | (0.01–0.40) | 3.98 | (3.50–4.89) | 0.24–3.78 | ||
Table presents estimated reference limits for patients with ulcerative colitis. See footnote for Table 1 for explanations.